Objective: To establish if patient anxiety pre-urodynamic investigation can be reduced by providing more information within the patient information sheet (PIS). Patients and Methods: Two prospective cohorts of consecutive patients (round 1, n = 98 and round 2, n = 94) were asked to complete a visual analogue scale (VAS) quantifying their anxiety prior to urodynamics (UDS) and again after UDS quantifying their anxiety of potentially repeating UDS. Patients in round 1 received the standard hospital PIS. Concurrently with round 1, a parallel group of patients (n = 95) completed a questionnaire regarding their experience of UDS and their post-UDS complications. This information was incorporated into a revised PIS used in round 2. Results: In both rounds, the VAS reduced post-UDS (Wilcoxon matched-pairs test p < 0.001). In females, pre-UDS VAS was significantly higher in round 2 than round 1 (Mann-Whitney U test p = 0.037). In males, pre-UDS VAS was lower in round 2 than round 1, but this difference was not statistically significant (Mann-Whitney U test p = 0.112). Post-UDS VAS was remarkably similar between round 1 and 2. Conclusions: Patients are less anxious about having repeat UDS regardless of the depth of information provided. However, more detailed information before UDS failed to significantly reduce patient anxiety.

Keywords:
Urodynamics, Anxiety, Patient information
This content is only available via PDF.
© 2011 S. Karger AG, Basel
2011
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.